Joyce K. Randolph

908 total citations
23 papers, 781 citations indexed

About

Joyce K. Randolph is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, Joyce K. Randolph has authored 23 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Toxicology. Recurrent topics in Joyce K. Randolph's work include Cancer therapeutics and mechanisms (11 papers), DNA Repair Mechanisms (5 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Joyce K. Randolph is often cited by papers focused on Cancer therapeutics and mechanisms (11 papers), DNA Repair Mechanisms (5 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Joyce K. Randolph collaborates with scholars based in United States. Joyce K. Randolph's co-authors include David A. Gewirtz, Frank A. Fornari, Jack C. Yalowich, M K Ritke, I. David Goldman, J. Courtland White, Michael S. Orr, W. David Jarvis, Steven Grant and Amy Ellis and has published in prestigious journals such as Hepatology, Biochemical and Biophysical Research Communications and Archives of Biochemistry and Biophysics.

In The Last Decade

Joyce K. Randolph

23 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joyce K. Randolph United States 13 415 319 95 90 70 23 781
M K Ritke United States 9 410 1.0× 221 0.7× 90 0.9× 56 0.6× 64 0.9× 9 632
Lorraine A. Cazenave United States 6 558 1.3× 847 2.7× 95 1.0× 95 1.1× 46 0.7× 7 1.3k
Sayed S. Daoud United States 17 459 1.1× 294 0.9× 63 0.7× 94 1.0× 36 0.5× 38 771
Teresa Dasdia Italy 20 605 1.5× 497 1.6× 42 0.4× 51 0.6× 61 0.9× 41 1.2k
S Kirschenbaum United States 7 576 1.4× 342 1.1× 51 0.5× 29 0.3× 40 0.6× 9 728
Johann Rastetter Germany 18 590 1.4× 269 0.8× 106 1.1× 113 1.3× 48 0.7× 72 1.1k
Aurelio Di Marco Italy 17 468 1.1× 407 1.3× 24 0.3× 47 0.5× 33 0.5× 33 924
Hazel C. Cable United Kingdom 13 396 1.0× 123 0.4× 204 2.1× 60 0.7× 55 0.8× 20 847
Lisa M. Hollingshead United Kingdom 5 189 0.5× 170 0.5× 28 0.3× 26 0.3× 36 0.5× 5 583
Xiaohang Qiao Netherlands 11 481 1.2× 277 0.9× 78 0.8× 79 0.9× 75 1.1× 14 885

Countries citing papers authored by Joyce K. Randolph

Since Specialization
Citations

This map shows the geographic impact of Joyce K. Randolph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce K. Randolph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce K. Randolph more than expected).

Fields of papers citing papers by Joyce K. Randolph

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joyce K. Randolph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce K. Randolph. The network helps show where Joyce K. Randolph may publish in the future.

Co-authorship network of co-authors of Joyce K. Randolph

This figure shows the co-authorship network connecting the top 25 collaborators of Joyce K. Randolph. A scholar is included among the top collaborators of Joyce K. Randolph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce K. Randolph. Joyce K. Randolph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gewirtz, David A., et al.. (2001). Rb Dephosphorylation and Suppression of E2F Activity in Human Breast Tumor Cells Exposed to a Pharmacological Concentration of Estradiol. Archives of Biochemistry and Biophysics. 388(2). 243–252. 3 indexed citations
4.
5.
Fornari, Frank A., W. David Jarvis, Steven Grant, et al.. (1996). Growth arrest and non-apoptotic cell death associated with the suppression of c-myc Expression in MCF-7 breast tumor cells following acute exposure to doxorubicin. Biochemical Pharmacology. 51(7). 931–940. 63 indexed citations
6.
Orr, Michael S., Frank A. Fornari, Joyce K. Randolph, & David A. Gewirtz. (1995). Transcriptional down-regulation of c-myc expression in the MCF-7 breast tumor cell line by the topoisomerase 11 inhibitor, VM-26. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1262(2-3). 139–145. 7 indexed citations
7.
Bunch, Roderick T., Lawrence F. Povirk, Michael S. Orr, et al.. (1994). Influence of amsacrine (m-AMSA) on bulk and gene-specific DNA damage and c-myc expression in MCF-7 breast tumor cells. Biochemical Pharmacology. 47(2). 317–329. 18 indexed citations
8.
Randolph, Joyce K., et al.. (1994). Antagonism between tamoxifen and doxorubicin in the MCF-7 human breast tumor cell line. Biochemical Pharmacology. 47(8). 1449–1452. 32 indexed citations
9.
Fornari, Frank A., Joyce K. Randolph, Jack C. Yalowich, M K Ritke, & David A. Gewirtz. (1994). Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells.. Molecular Pharmacology. 45(4). 649–656. 367 indexed citations
10.
Gewirtz, David A., Michael S. Orr, Frank A. Fornari, et al.. (1993). Dissociation between bulk damage to DNA and the antiproliferative activity of teniposide (VM-26) in the MCF-7 breast tumor cell line: evidence for induction of gene-specific damage and alterations in gene expression.. PubMed. 53(15). 3547–54. 17 indexed citations
11.
Ellis, Amy, Roderick T. Bunch, Joyce K. Randolph, et al.. (1992). Components of intrinsic drug resistance in the rat hepatoma. Biochemical Pharmacology. 43(2). 331–342. 8 indexed citations
12.
Randolph, Joyce K., et al.. (1990). Biochemical lesions in DNA associated with the antiproliferative effects of mitoxantrone in the hepatoma cell. Biochemical Pharmacology. 39(10). 1549–1556. 12 indexed citations
13.
Ellis, Amy, et al.. (1989). Enhanced sensitivity of the rat hepatoma cell to the daunorubicin analogue 4-demethoxydaunorubicin associated with induction of DNA damage.. PubMed. 49(17). 4846–51. 6 indexed citations
14.
Gewirtz, David A., Amy Ellis, Joyce K. Randolph, et al.. (1989). Expression of protein-associated DNA damage in the alkaline elution assay in the absence of enzymatic deproteinization.. PubMed. 1(3). 175–80. 2 indexed citations
15.
Gewirtz, David A., et al.. (1985). Induction of methotrexate release from rat hepatocytes in suspension by α-adrenergic agents: Involvement of calcium and metabolic energy. Archives of Biochemistry and Biophysics. 237(1). 237–243. 1 indexed citations
16.
Gewirtz, David A., et al.. (1984). Interaction of probenecid with methotrexate transport and release in the isolated rat hepatocyte in suspension.. PubMed. 44(9). 3846–50. 11 indexed citations
17.
Gewirtz, David A., Joyce K. Randolph, & David Goldman. (1984). Induction of Taurocholate Release from Isolated Rat Hepatocytes in Suspension by α-Adrenergie Agents and Vasopressin: Implications for Control of Bile Salt Secretion. Hepatology. 4(2). 205–212. 19 indexed citations
18.
Gewirtz, David A., Joyce K. Randolph, & I. David Goldman. (1982). Catecholamine-induced release of the folic acid analogue, methotrexate, from rat hepatocytes in suspension. An alpha-adrenergic phenomenon.. Molecular Pharmacology. 22(2). 493–499. 8 indexed citations
19.
Gewirtz, David A., Joyce K. Randolph, & I. David Goldman. (1981). Efflux in isolated hepatocytes as a possible correlate of secretion in, vivo: Induced exit of the folic acid analog methotrexate, by dibutyryl cyclic AMP or isobutyl methyl xanthine. Biochemical and Biophysical Research Communications. 101(2). 366–374. 8 indexed citations
20.
Gewirtz, David A., Joyce K. Randolph, & I. David Goldman. (1980). Potent bile salt and organic anion inhibition of methotrexate uptake and accumulation in the freshly isolated rat hepatocyte.. PubMed. 40(6). 1852–7. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026